Literature DB >> 1283329

Loss of heterozygosity on the long arm of chromosome 22 in pheochromocytoma.

N Tanaka1, I Nishisho, M Yamamoto, A Miya, E Shin, K Karakawa, S Fujita, T Kobayashi, G A Rouleau, T Mori.   

Abstract

To identify the putative common deleted region on the long arm of chromosome 22 in pheochromocytoma, restriction fragment length polymorphism analysis was performed in 17 pheochromocytomas. All cases were heterozygous for at least one of the eight marker loci on 22q. Loss of heterozygosity (LOH) was observed in nine pheochromocytomas, of which eight were hereditary and one nonhereditary. Three pheochromocytomas had interstitial deletions that enabled us to localize the commonly deleted region as distal to D22S10 and proximal to D22S22. Hereditary pheochromocytoma frequently occurs in association with medullary thyroid carcinoma (MTC). Therefore, we also studied allelic loss on 22q in 23 hereditary MTCs. Only one of the MTCs showed LOH on 22q. Recent studies have mapped tumor suppressor loci associated with meningioma and neurofibromatosis type 2 (NF2) to 22q. The commonly deleted region in pheochromocytoma found by us encompasses the regions to which tumor suppressor genes associated with NF2 and meningioma have been mapped. The exact role of the pheochromocytoma tumor suppressor gene on 22q and its relationship to the suppressor genes involved in NF2 and meningioma remain unknown.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1283329     DOI: 10.1002/gcc.2870050416

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  9 in total

1.  Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas.

Authors:  H Dannenberg; E J Speel; J Zhao; P Saremaslani; E van Der Harst; J Roth; P U Heitz; H J Bonjer; W N Dinjens; W J Mooi; P Komminoth; R R de Krijger
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology.

Authors:  E Edström; E Mahlamäki; B Nord; M Kjellman; R Karhu; A Höög; N Goncharov; B T Teh; M Bäckdahl; C Larsson
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

Review 3.  Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.

Authors:  Hilde Dannenberg; Paul Komminoth; Winand N M Dinjens; Ernst Jan M Speel; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

4.  ATF4 Targets RET for Degradation and Is a Candidate Tumor Suppressor Gene in Medullary Thyroid Cancer.

Authors:  Rozita Bagheri-Yarmand; Michelle D Williams; Elizabeth G Grubbs; Robert F Gagel
Journal:  J Clin Endocrinol Metab       Date:  2017-03-01       Impact factor: 5.958

5.  Isolation and mapping of cosmid markers on human chromosome 22, including one within the submicroscopically deleted region of DiGeorge syndrome.

Authors:  H Kurahashi; K Akagi; K Karakawa; T Nakamura; J P Dumanski; T Sano; S Okada; S Takai; I Nishisho
Journal:  Hum Genet       Date:  1994-03       Impact factor: 4.132

6.  ATF4 loss of heterozygosity is associated with poor overall survival in medullary thyroid carcinoma.

Authors:  Michelle D Williams; Junsheng Ma; Elizabeth G Grubbs; Robert F Gagel; Rozita Bagheri-Yarmand
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

7.  Evaluation of Endocrine Neoplasms Using Fine Needle Aspiration Biopsy.

Authors:  Mary E. Barcus; Celeste N. Powers
Journal:  Endocr Pathol       Date:  2000       Impact factor: 4.056

8.  Malignant pheochromocytoma with cerebral and skull metastasis: A case report and literature review.

Authors:  Jun-Chen Chen; Dong-Zhou Zhuang; Cheng Luo; Wei-Qiang Chen
Journal:  World J Clin Cases       Date:  2021-04-26       Impact factor: 1.337

9.  Deletion mapping of chromosome 1p and 22q in pheochromocytoma.

Authors:  E Shin; S Fujita; K Takami; H Kurahashi; Y Kurita; T Kobayashi; T Mori; I Nishisho; S Takai
Journal:  Jpn J Cancer Res       Date:  1993-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.